By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Following Thermo Fisher Scientific's announcement today that it will issue senior notes to fund in part its $3.5 billion acquisition of Phadia, ratings agency Fitch assigned an "A-" rating to the notes.

Thermo Fisher has not yet disclosed the terms of the notes or how much it expects to raise in the offering.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.